William Valle

Director

William Valle (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in TriSalus Life Sciences, Inc. (TLSI). Across 1 priced purchase filing, the average 21-session return was -28.3% from execution and -28.3% from disclosure (delay-adjusted; derived). The largest single filing was $125K of TLSI (30,487 sh × $4.10, as filed), executed Feb 23.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

-28.3%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

-28.3%

same 1 filings, from disclosure

Filings, ttm

1 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$125K

shares × price, as filed

Last traded

Feb 23

Filed Feb 23

Open performance→

Volume by month

Buys $125K Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

TLSI

TriSalus Life Sciences, Inc. TLSI · 1 buy · 0 sells 1 filing

Recent filings

TLSIPURCHASE TriSalus Life Sciences, Inc. View filing → $125K
30,487 sh × $4.10
Exec Feb 23
Filed Feb 23 · 4:08 PM ET